gliclazide and dinoprost

gliclazide has been researched along with dinoprost in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Fujino, H; Regan, JW1

Other Studies

3 other study(ies) available for gliclazide and dinoprost

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Prostaglandin F2alpha amplifies tumor necrosis factor-alpha promoter activity by the FPB prostanoid receptor.
    Biochemical and biophysical research communications, 2004, May-14, Volume: 317, Issue:4

    Topics: Animals; Cell Line; Dinoprost; Drug Synergism; Egtazic Acid; Enterotoxins; Enzyme Inhibitors; Genes, Reporter; Glycyrrhetinic Acid; Humans; Indoles; Luciferases; Maleimides; Promoter Regions, Genetic; Protein Isoforms; Protein Kinase C; Receptors, Prostaglandin; rho GTP-Binding Proteins; Sheep; Transfection; Tumor Necrosis Factor-alpha

2004